Veterinary Point of Care Diagnostics Market Size & Growth Forecast 2027–2036, By Segments (Animal Type, End-use, Product, Sample Type, Testing Category, Indication), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Veterinary Point of Care Diagnostics Market size stood at USD 3.1 billion in 2026 and is predicted to grow at a 9.88% CAGR from 2027 to 2036, exceeding USD 7.95 billion by 2036. The industry revenue for 2027 is estimated at USD 3.36 billion.
Get more details on this report
Request Free Sample ReportVeterinary Point of Care Diagnostics Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 50.77% share in 2026, supported by established veterinary infrastructure and routine use of rapid in-clinic diagnostics for treatment decisions and wellness monitoring.
- Asia Pacific is expected to grow at a 12.77% CAGR as clinics adopt compact on-site diagnostic systems, improving disease detection, clinical decision-making, and access to veterinary care.
Segment Momentum
- Companion Animals held a 62.99% share in 2026 because frequent veterinary visits and the need for immediate diagnostic results support rapid treatment decisions and ongoing preventive care.
- Home Care Settings are growing fastest as pet owners increasingly adopt convenient monitoring solutions that reduce clinic visits while supporting timely health checks and continuous animal care.
Market Expansion Drivers
- Rising companion animal healthcare spending driving rapid adoption of in-clinic diagnostic testing.
- Increasing zoonotic disease monitoring accelerating livestock and public health diagnostic deployment.
- Expansion of pet insurance and decentralized veterinary care enabling routine rapid diagnostics.
Leading Market Participants
- Leading players in the veterinary point of care diagnostics market include IDEXX Laboratories, Inc. (United States), Zoetis Inc. (United States), Virbac S.A. (France), Thermo Fisher Scientific Inc. (United States), FUJIFILM Holdings Corporation (Japan), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Woodley Equipment Company Ltd. (United Kingdom), Getein Biotech, Inc. (China), Randox Laboratories Ltd. (United Kingdom).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 3.1 billion
- 2027 Estimated Market Size: USD 3.36 billion.
- Projected Market Size: USD 7.95 billion by 2036
- Growth Forecast: 9.88% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Companion Animals (Animal Type) | Veterinary Hospitals & Clinics (End-use) | Consumables, Reagents, & Kits (Product) | Blood/Plasma/Serum (Sample Type) | Parasitology (Testing Category) | Infectious Disease (Indication)
- Emerging Opportunity Segment: Livestock Animals (Animal Type) | Home Care Settings (End-use) | Instruments & Devices (Product) | Urine (Sample Type) | Hematology (Testing Category) | Infectious Disease (Indication)
Market Growth Drivers and Industry Trends
Rising companion animal healthcare spending driving rapid adoption of in-clinic diagnostic testing
Higher spending on companion animal healthcare is accelerating the veterinary point of care diagnostics market as pet owners increasingly seek timely and comprehensive medical care for their animals. Greater willingness to invest in preventive care, chronic disease management, and diagnostic evaluation is prompting veterinary practices to expand their in-clinic testing capabilities. Point-of-care systems allow clinicians to obtain diagnostic information during consultations rather than relying entirely on external laboratories, helping support faster treatment decisions and more efficient case management. The growing emphasis on early disease detection and individualized veterinary care is also increasing the use of rapid testing across routine examinations, emergency cases, and ongoing monitoring of pets with health conditions.
Increasing zoonotic disease monitoring accelerating livestock and public health diagnostic deployment
Stronger attention to zoonotic disease surveillance is expanding diagnostic requirements across livestock management and veterinary public health, thereby propelling the veterinary point of care diagnostics market. Diseases that can move between animals and humans require rapid identification to support containment, treatment, and monitoring efforts, particularly in settings where laboratory access may be limited. On-site diagnostic technologies can help veterinary professionals and animal health authorities obtain timely information during herd investigations, disease outbreaks, and routine surveillance activities. Their portability and rapid turnaround are particularly valuable for decentralized environments, where immediate testing can assist decisions related to animal health management, biosecurity measures, and movement controls.
Expansion of pet insurance and decentralized veterinary care enabling routine rapid diagnostics
The wider availability of pet insurance and the growth of decentralized veterinary services are making routine diagnostic testing more accessible, strengthening demand in the veterinary point of care diagnostics market. Insurance coverage can reduce the financial barriers associated with diagnostic procedures, encouraging pet owners to pursue testing as part of preventive examinations and clinical evaluations. At the same time, mobile veterinary services, smaller clinics, and other decentralized care models require compact diagnostic solutions that can deliver useful results without dependence on centralized laboratory infrastructure. Rapid testing capabilities allow these providers to integrate diagnostics directly into consultations and treatment workflows, supporting more frequent testing for conditions requiring immediate clinical assessment.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Growing demand for veterinary point-of-care diagnostics | 4.00% | Short term (≤ 2 yrs) | North America, Europe (spillover: Asia Pacific) | Medium | Fast |
| Adoption in livestock and companion animal health monitoring | 3.50% | Medium term (2–5 yrs) | Europe, Asia Pacific (spillover: North America) | Medium | Moderate |
| Expansion of portable and rapid diagnostic devices | 2.90% | Long term (5+ yrs) | North America, Europe (spillover: Asia Pacific) | Medium | Slow |
| Rising companion animal healthcare spending driving rapid adoption of in-clinic diagnostic testing | 2.10% | Moderate | North America, Europe | High | Near Term |
| Increasing zoonotic disease monitoring accelerating livestock and public health diagnostic deployment | 1.80% | High | Asia Pacific, North America | High | Mid Term |
| Expansion of pet insurance and decentralized veterinary care enabling routine rapid diagnostics | 1.50% | Moderate | North America, Europe, Asia Pacific | High | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America dominated the veterinary point of care diagnostics market with a 50.77% share in 2026, supported by advanced veterinary healthcare infrastructure, high expenditure on companion animal care, and widespread adoption of rapid diagnostic technologies. Veterinary practices increasingly rely on point-of-care testing to obtain timely information for disease detection, treatment decisions, and routine health monitoring. Strong awareness of preventive animal healthcare is encouraging pet owners to seek earlier diagnosis, while sophisticated veterinary facilities have greater capacity to integrate diagnostic testing into clinical workflows. Growing demand for efficient, decentralized testing across companion animal and livestock settings is also supporting the use of portable and rapid diagnostic platforms.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is experiencing the fastest growth as veterinary healthcare infrastructure expands and awareness of animal health management increases. Rising companion animal ownership and greater attention to preventive veterinary care are creating new demand for accessible diagnostic solutions. At the same time, livestock production and animal disease management are encouraging broader use of rapid testing technologies that can support timely intervention and reduce the impact of illness. Improvements in veterinary clinics, laboratory capabilities, and diagnostic accessibility are helping extend point-of-care testing beyond major urban centers. Increasing investment in animal healthcare and growing recognition of early disease detection are expected to further support adoption throughout the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Diagnostic AdoptionGermany emphasizes high-accuracy diagnostic solutions for both companion and production animals. Veterinary practices in Germany are increasingly integrating in-clinic testing systems that support disease screening and preventive care while reducing dependence on centralized laboratories.
France 🇫🇷
Preventive Animal Health FocusFrance is increasingly using point-of-care diagnostics to strengthen preventive veterinary care and disease surveillance. Veterinary practices in France are seeking versatile testing platforms capable of supporting routine wellness screening and timely identification of infectious conditions.
Italy 🇮🇹
Expanding Clinic CapabilitiesItaly is seeing broader deployment of in-house diagnostic systems as veterinary clinics seek faster clinical insights and improved patient management. The Italian market is characterized by interest in cost-effective testing solutions that can support both companion animal and livestock applications.
Japan 🇯🇵
Aging Pet ManagementJapan's growing focus on managing chronic conditions in aging pets is supporting demand for accessible diagnostic tools. Veterinary clinics in Japan are prioritizing point-of-care systems that enable routine monitoring of metabolic and infectious diseases during a single patient visit.
South Korea 🇰🇷
Digitally Connected ClinicsSouth Korea is adopting veterinary diagnostic platforms that combine rapid testing with digital record management. The country's expanding pet healthcare sector is encouraging clinics to invest in compact diagnostic equipment that enhances service efficiency and supports preventive medicine programs.
United States 🇺🇸
Companion Care InnovationThe U.S. veterinary point of care diagnostics market is benefiting from rising demand for rapid testing in companion animal clinics and emergency settings. Veterinary providers in the U.S. are adopting portable analyzers and digital diagnostic platforms to improve clinical decision-making and treatment turnaround times.
Segment Leadership and Growth Trends
Veterinary Point of Care Diagnostics Market Share (%), by Animal Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportAnimal Type Segment Analysis: Companion Animals (Largest Segment) vs Livestock Animals (Fastest-Growing Segment)
Companion animals accounted for the largest share of the veterinary point of care diagnostics market, representing 62.99% in 2026. Increasing emphasis on preventive veterinary care and routine health monitoring is supporting greater use of rapid diagnostic testing for pets. Owners are becoming more attentive to early identification of health conditions, while veterinary providers increasingly rely on accessible diagnostic tools to support faster clinical decision-making. The expansion of specialized pet healthcare and greater willingness to invest in animal wellness are reinforcing demand for point of care diagnostics within companion animal care.
Livestock animals represent the fastest-growing animal type segment as producers increasingly prioritize animal health, disease surveillance, and productivity management. Rapid diagnostic capabilities can help support timely identification of health issues within livestock populations, where delays in detection can affect herd or flock performance and create broader economic consequences. Growing emphasis on preventive herd management, biosecurity, and efficient veterinary intervention is encouraging greater adoption of point of care testing, particularly where rapid results can support immediate management decisions.
End-use Segment Analysis: Veterinary Hospitals & Clinics (Largest Segment) vs Home Care Settings (Fastest-Growing Segment)
Veterinary hospitals & clinics held the largest share of the veterinary point of care diagnostics market in 2026. These facilities remain central to animal diagnosis because they provide professional examination, treatment, monitoring, and access to a broader range of diagnostic services. Point of care technologies enable veterinary professionals to obtain timely information during consultations and support more efficient clinical workflows. Increasing demand for comprehensive veterinary services and greater emphasis on rapid diagnosis continue to strengthen adoption across hospitals and clinics.
Home care settings are experiencing the fastest growth as pet owners increasingly seek convenient ways to monitor animal health outside traditional clinical environments. The development of simpler and more accessible diagnostic technologies is making decentralized testing more practical for routine monitoring and selected health-management needs. Rising attention to preventive pet care, convenience, and continuous observation is encouraging broader use of diagnostic tools in home settings, creating new opportunities for point of care solutions beyond conventional veterinary facilities.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Animal Type | Companion Animals, Livestock Animals | Companion Animals | Livestock Animals |
| End-use | Veterinary Hospitals & Clinics, Home Care Settings, Others | Veterinary Hospitals & Clinics | Home Care Settings |
| Product | Consumables, Reagents, & Kits, Instruments & Devices | Consumables, Reagents, & Kits | Instruments & Devices |
| Sample Type | Blood/Plasma/Serum, Urine, Fecal, Others | Blood/Plasma/Serum | Urine |
| Testing Category | Hematology, Diagnostic Imaging, Bacteriology, Virology, Cytology, Clinical Chemistry, Parasitology, Serology, Others | Parasitology | Hematology |
| Indication | Infectious Disease, General Ailments, Others | Infectious Disease | Infectious Disease |
Competitive Landscape and Market Positioning
Key companies in the veterinary point of care diagnostics market:
1. IDEXX Laboratories Inc. (United States)
2. Zoetis Inc. (United States)
3. Virbac S.A. (France)
4. Thermo Fisher Scientific Inc. (United States)
5. FUJIFILM Holdings Corporation (Japan)
6. Shenzhen Mindray Bio-Medical Electronics Co. Ltd. (China)
7. Woodley Equipment Company Ltd. (United Kingdom)
8. Getein Biotech Inc. (China)
9. Randox Laboratories Ltd. (United Kingdom)
Rapid advances in diagnostic technologies are supporting the veterinary point of care diagnostics market, with increasing integration of portable analyzers, AI-assisted interpretation, and digital connectivity. Product innovation is enabling faster clinical decision-making and improving animal healthcare outcomes.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| IDEXX Laboratories Inc. (United States) | |||||||
| Zoetis Inc. (United States) | |||||||
| Virbac S.A. (France) | |||||||
| Thermo Fisher Scientific Inc. (United States) | |||||||
| FUJIFILM Holdings Corporation (Japan) | |||||||
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd. (China) | |||||||
| Woodley Equipment Company Ltd. (United Kingdom) | |||||||
| Getein Biotech Inc. (China) | |||||||
| Randox Laboratories Ltd. (United Kingdom). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Zoetis | Apr-26 | Zoetis expanded the capabilities of its Vetscan OptiCell point-of-care hematology analyzer by adding new diagnostic parameters, including CHCM and PCT. The enhancement strengthens in-clinic blood analysis by providing more comprehensive real-time hematology insights, reinforcing the company's position in veterinary point-of-care diagnostics. |
| bioMérieux | Jun-25 | bioMérieux launched VETFIRE, a ready-to-use PCR diagnostic kit for equine infectious respiratory diseases capable of simultaneously detecting seven respiratory pathogens. The launch expands the company's veterinary point-of-care infectious disease testing portfolio with a specialized molecular diagnostic solution for equine healthcare. |
| IDEXX Laboratories | Jun-25 | IDEXX Laboratories introduced IDEXX Cancer Dx, a canine lymphoma diagnostic panel priced at USD 15 that delivers results within two to three days. The launch expands the company's veterinary oncology diagnostics portfolio and strengthens access to rapid cancer testing for companion animals. |
| Antech Diagnostics | Mar-25 | Antech Diagnostics launched truRapid FOUR, an in-house canine vector-borne disease screening test capable of detecting antibodies to Anaplasma spp., Ehrlichia spp., Lyme C6 and heartworm antigen. The product broadens rapid in-clinic diagnostic capabilities for veterinary practices. |
| Zoetis | Jan-25 | Zoetis introduced the AI-powered Vetscan OptiCell, a cartridge-based, screenless point-of-care hematology analyzer delivering complete blood count results with reference laboratory-quality accuracy within minutes. The launch advances AI adoption in veterinary diagnostics while improving workflow efficiency in clinics. |
| Zoetis | Jan-25 | Zoetis unveiled AI Masses for its Vetscan Imagyst platform, enabling rapid lesion screening with a commercial rollout planned for the second quarter of 2025. The addition expands AI-enabled diagnostic capabilities and strengthens the company's veterinary point-of-care imaging portfolio. |
| Mars Petcare | Jun-23 | Mars Petcare acquired Heska to expand its veterinary point-of-care diagnostics capabilities and strengthen its diagnostic product portfolio. The acquisition enhances the company's market presence by broadening access to integrated animal diagnostic solutions. |
| VolitionRx Limited | Mar-22 | VolitionRx signed an exclusive global supply and licensing agreement with Heska Corporation to commercialize the Nu.Q Vet Cancer Screening test. The agreement expands global distribution opportunities for veterinary cancer diagnostics and strengthens the companies' long-term collaboration. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Veterinary Point of Care Diagnostics Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Diagnostic Technology | Immunoassay-Based Diagnostics, Molecular Diagnostics, Clinical Chemistry & Hematology Analyzers, Imaging-Based Diagnostics, Other Technologies |
| Veterinary Practice Size | Small & Independent Practices, Mid-Sized Veterinary Practices, Large Veterinary Hospitals & Specialty Centers, Veterinary Hospital Networks |
| Purchase Model | Direct Purchase, Distributor-Mediated Purchase, Reagent Rental & Placement Agreements, Subscription & Managed Testing Models |
Veterinary Point of Care Diagnostics Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Veterinary Digital Health Integration Outlook |
|
| Companion Animal Diagnostics Opportunity Mapping |
|
| Diagnostic Accessibility Expansion Strategy |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current revenue of the veterinary point of care diagnostics market?
What is the projected value of the veterinary point of care diagnostics industry by 2036?
How is rising companion animal healthcare spending shaping the adoption of in-clinic point-of-care diagnostics?
What is driving the increasing role of point-of-care diagnostics in livestock and zoonotic disease management?
Why are companion animals the largest animal type segment in the veterinary point of care diagnostics market?
Why are home care settings the fastest-growing end-use segment in the veterinary point of care diagnostics market?
Why is North America the leading veterinary point of care diagnostics market?
What is driving veterinary point of care diagnostics growth in Asia Pacific?
Which companies are driving growth in the veterinary point of care diagnostics landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization